RxSight. IPO

RxSight is a Californian medical tech company, working to optimize after catarct surgery patients’ vision. The patent system of adjustable lens RxSight Light consists of the adjustable lens RxSight Light and of the Light Delivery Device RxSight. This system presents the world’s first and only adjustable intraocular lens (IOL) that allows you and your physician to optimize and to customize your vision after cataract surgery.  

The IPO underwriters are  
JP Morgan
BofA Securities
SVB Leerink
Wells Fargo Securities
BTIG